E88.3 is a billable/specific diagnosis code from the 2025 ICD-10-CM used to classify the following condition: Tumor lysis syndrome.
Inclusion term
Tumor lysis syndrome (spontaneous)
Tumor lysis syndrome following antineoplastic drug chemotherapy
Use additional code
Code for adverse effect, if applicable, to identify drug (T45.1X5)
Versions
2025
No changes
2024
No changes
2023
No changes
2022
No changes
2021
No changes
2020
No changes
2019
No changes
2018
No changes
2017
No changes
2016
New code